Company Description
AstraZeneca's products run the gamut from A (breast cancer drug Arimidex) to Z (migraine treatment Zomig). One of the world's...
Key AstraZeneca Financials
| Company Type | Public - NYSE: AZN; London: AZN Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $29,559.0 |
| 2006 Employees | 66,000 |
More AstraZeneca Financials (8 pages)
Latest AstraZeneca Jobs jobs by Indeed
Rankings
- Dow Jones STOXX 50
- #83 in FT Global 500
- FTSE 100
Competition
Competitive Landscape for Pharmaceutical Manufacture and Sale
The industry is marked by rapid advances in scientific knowledge that produce ever-more effective medicines. Profitability is determined mainly by the ability to discover new drugs....
Read more about AstraZeneca's competition across multiple industries
Top AstraZeneca Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
AstraZeneca Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman | Louis Schweitzer | Network | E-mail |
| CEO and Board Member | David R. Brennan | Network | E-mail |
| Executive Director, Development | John Patterson | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current AstraZeneca News
- 2 drug firms to appeal $114M price fraud verdict [AP Financial News] (03 Jul 2008 18:26:00 EDT)
- 2 drug firms to appeal $114M price fraud verdict [AP Financial News] (03 Jul 2008 18:26:00 EDT)
- BioWorld Today July 3, 2008 [BioWorld Today] (03 Jul 2008 00:01:00 EDT)